Disparate roles for C. elegans DNA translocase paralogs RAD-54.L and RAD-54.B in meiotic prophase germ cells
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Kei Yamaya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Caenorhabditis elegans Proteins, DNA Helicases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
RAD54 family DNA translocases partner with RAD51 recombinases to ensure stable genome inheritance, exhibiting biochemical activities both in promoting recombinase removal and in stabilizing recombinase association with DNA. Understanding how such disparate activities of RAD54 paralogs align with their biological roles is an ongoing challenge. Here we investigate the in vivo functions of Caenorhabditis elegans RAD54 paralogs RAD-54.L and RAD-54.B during meiotic prophase, revealing distinct contributions to the dynamics of RAD-51 association with DNA and to the progression of meiotic double-strand break repair (DSBR). While RAD-54.L is essential for RAD-51 removal from meiotic DSBR sites to enable recombination progression, RAD-54.B is largely dispensable for meiotic DSBR. However, RAD-54.B is required to prevent hyperaccumulation of RAD-51 on unbroken DNA during the meiotic sub-stage when DSBs and early recombination intermediates form. Moreover, DSB-independent hyperaccumulation of RAD-51 foci in the absence of RAD-54.B is RAD-54.L-dependent, revealing a hidden activity of RAD-54.L in promoting promiscuous RAD-51 association that is antagonized by RAD-54.B. We propose a model wherein a division of labor among RAD-54 paralogs allows germ cells to ramp up their capacity for efficient homologous recombination that is crucial to successful meiosis while counteracting potentially deleterious effects of unproductive RAD-51 association with unbroken DNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA.
- State Key Laboratory of Non-food Biomass and Enzyme Technology, Guangxi Academy of Sciences, 530007 Nanning, China.
- IBS Center for Genomic Integrity and Department for Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan, Korea.
- Swiss Institute for Experimental Cancer Research (ISREC) and School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
- Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Anne M Villeneuve
Förderung
- NIH HHS
- NIGMS NIH HHS
- NCRR NIH HHS
- American Cancer Society Research Professor Award
- National Institutes of Health
- Stanford Graduate Fellowship
- National Center for Research Resources
- Natural Science Foundation grant of Guangxi Zhuang Autonomous Region
Zitieren
APA
Yamaya, K., Wang, B., Memar, N., Odiba, A. S., Woglar, A., Gartner, A., & Villeneuve, A. M. (2023). Disparate roles for C. elegans DNA translocase paralogs RAD-54.L and RAD-54.B in meiotic prophase germ cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad638
Vancouver
Yamaya K, Wang B, Memar N, Odiba AS, Woglar A, Gartner A, et al. Disparate roles for C. elegans DNA translocase paralogs RAD-54.L and RAD-54.B in meiotic prophase germ cells. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad638
BibTeX
@article{Yamaya2023,
author = {Yamaya, Kei and Wang, Bin and Memar, Nadin and Odiba, Arome Solomon and Woglar, Alexander and Gartner, Anton and Villeneuve, Anne M},
title = {Disparate roles for C. elegans DNA translocase paralogs RAD-54.L and RAD-54.B in meiotic prophase germ cells},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad638}
}
EUVIMED